Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Other income

v3.22.1
Other income
12 Months Ended
Dec. 31, 2021
Other income

 

4. Other income

 

   

Year ended

December 31,

    Year ended December 31,    

Year ended

December 31,

 
    2021     2020     2019  
    £     £     £  
Grant income     6,381       547,928       1,163,624  
Other income     -       21,272       397,642  
Other (expenses)/income     6,381       569,200       1,561,266  

 

Grant income received in the years ended December 31, 2021 and 2020 was represented by payments under the Coronavirus Job Retention Scheme. Grant income received in the year ended December 31, 2019 was represented by research and development related grant funding.

 

Unrealized exchange differences in the period relate to retranslation of the US dollar denominated convertible loan notes as at the period end.

 

Other income includes research and development tax credits totaling £Nil (2020: £6,772 and 2019: £394,642).

 

 

TC BIOPHARM (HOLDINGS) PLC

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)